GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare Services Acquisition Corp (NAS:HCAR) » Definitions » EBIT

Healthcare Services Acquisition (Healthcare Services Acquisition) EBIT : $-2.41 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Healthcare Services Acquisition EBIT?

Healthcare Services Acquisition's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2022 was $-0.26 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $-2.41 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Healthcare Services Acquisition's annualized ROC % for the quarter that ended in Sep. 2022 was -0.27%. Healthcare Services Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Healthcare Services Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -0.58%.

Healthcare Services Acquisition EBIT Historical Data

The historical data trend for Healthcare Services Acquisition's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare Services Acquisition EBIT Chart

Healthcare Services Acquisition Annual Data
Trend Dec20 Dec21
EBIT
- -4.11

Healthcare Services Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBIT Get a 7-Day Free Trial -1.10 -0.20 -0.91 -1.04 -0.26

Competitive Comparison of Healthcare Services Acquisition's EBIT

For the Shell Companies subindustry, Healthcare Services Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthcare Services Acquisition's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Healthcare Services Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Healthcare Services Acquisition's EV-to-EBIT falls into.


Healthcare Services Acquisition EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Services Acquisition  (NAS:HCAR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Healthcare Services Acquisition's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

ROC % (Q: Sep. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2022 ) + Invested Capital (Q: Sep. 2022 ))/ count )
=-1.044 * ( 1 - 12.77% )/( (331.566 + 332.961)/ 2 )
=-0.9106812/332.2635
=-0.27 %

where

Invested Capital(Q: Jun. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=332.04 - 0.212 - ( 0.282 - max(0, 0.212 - 0.474+0.282))
=331.566

Invested Capital(Q: Sep. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=333.139 - 0.587 - ( 0.076 - max(0, 0.587 - 0.178+0.076))
=332.961

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Healthcare Services Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2022  Q: Sep. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.044/( ( (0 + max(-0.02, 0)) + (0 + max(-0.485, 0)) )/ 2 )
=-1.044/( ( 0 + 0 )/ 2 )
=-1.044/0
= %

where Working Capital is:

Working Capital(Q: Jun. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.192) - (0.212 + 0 + 0)
=-0.02

Working Capital(Q: Sep. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.102) - (0.587 + 0 + 0)
=-0.485

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Healthcare Services Acquisition's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2022 )
=-2.409/418.664
=-0.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Services Acquisition EBIT Related Terms

Thank you for viewing the detailed overview of Healthcare Services Acquisition's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthcare Services Acquisition (Healthcare Services Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare Services Acquisition Corp (NAS:HCAR) » Definitions » EBIT
Comparable Companies
GATE BYTS GMBT CLAA SVFC DTOC BCSA VCXB FACA PIAI GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
7809 Woodmont Avenue, Suite 200, Bethesda, MD, USA, 20814
Website
https://www.healthcarespac.com
Healthcare Services Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Brian T Griffin director
David T Blair director, officer: CEO and Chairman of the Board HEALTHEXTRAS, INC, 800 KING FARM BLVD, 4TH FL, ROCKVILLE MD 20850
Michael P Donovan director HEALTHEXTRAS, INC, 800 KING FARM BLVD, 4TH FL, ROCKVILLE MD 20850
Jeanne L. Manischewitz director 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Martin J. Payne director, officer: President and Director 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Joshua B. Lynn officer: Chief Financial Officer 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Tao Tan officer: Chief Operating Officer 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814